140 related articles for article (PubMed ID: 38431445)
1. Intravenous Hemin, a potential heme oxygenase-1 activator, does not protect from post-ERCP acute pancreatitis in humans: Results of a randomized multicentric multinational placebo-controlled trial.
Yared RA; Chen CC; Vandorpe A; Arvanitakis M; Delhaye M; Viesca MFY; Huberty V; Blero D; Toussaint E; Hittelet A; Verset D; Margos W; Le Moine O; Njimi H; Liao WC; Devière J; Lemmers A
Pancreatology; 2024 May; 24(3):363-369. PubMed ID: 38431445
[TBL] [Abstract][Full Text] [Related]
2. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
3. IV Ibuprofen for Prevention of Post-ERCP Pancreatitis in Children: A Randomized Placebo-controlled Feasibility Study.
Troendle DM; Gurram B; Huang R; Barth BA
J Pediatr Gastroenterol Nutr; 2020 Jan; 70(1):121-126. PubMed ID: 31651801
[TBL] [Abstract][Full Text] [Related]
4. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
Lyu Y; Cheng Y; Wang B; Xu Y; Du W
BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
[TBL] [Abstract][Full Text] [Related]
5. Lactated Ringer's solution in combination with rectal indomethacin for prevention of post-ERCP pancreatitis and readmission: a prospective randomized, double-blinded, placebo-controlled trial.
Mok SRS; Ho HC; Shah P; Patel M; Gaughan JP; Elfant AB
Gastrointest Endosc; 2017 May; 85(5):1005-1013. PubMed ID: 27816497
[TBL] [Abstract][Full Text] [Related]
6. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
[TBL] [Abstract][Full Text] [Related]
7. Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial.
Fogel EL; Lehman GA; Tarnasky P; Cote GA; Schmidt SE; Waljee AK; Higgins PDR; Watkins JL; Sherman S; Kwon RSY; Elta GH; Easler JJ; Pleskow DK; Scheiman JM; El Hajj II; Guda NM; Gromski MA; McHenry L; Arol S; Korsnes S; Suarez AL; Spitzer R; Miller M; Hofbauer M; Elmunzer BJ;
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):132-141. PubMed ID: 31780277
[TBL] [Abstract][Full Text] [Related]
8. Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial.
Uchino R; Isayama H; Tsujino T; Sasahira N; Ito Y; Matsubara S; Takahara N; Arizumi T; Toda N; Mohri D; Togawa O; Yagioka H; Yanagihara Y; Nakajima K; Akiyama D; Hamada T; Miyabayashi K; Mizuno S; Kawakubo K; Kogure H; Sasaki T; Yamamoto N; Nakai Y; Hirano K; Tada M; Koike K
Gastrointest Endosc; 2013 Dec; 78(6):842-850. PubMed ID: 23910063
[TBL] [Abstract][Full Text] [Related]
9. Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.
Hauser G; Blažević I; Salkić N; Poropat G; Giljača V; Bulić Z; Štimac D
Surg Endosc; 2017 Feb; 31(2):602-610. PubMed ID: 27317032
[TBL] [Abstract][Full Text] [Related]
10. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
[TBL] [Abstract][Full Text] [Related]
11. Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients.
Levenick JM; Gordon SR; Fadden LL; Levy LC; Rockacy MJ; Hyder SM; Lacy BE; Bensen SP; Parr DD; Gardner TB
Gastroenterology; 2016 Apr; 150(4):911-7; quiz e19. PubMed ID: 26775631
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using Temporary Pancreatic Stents Versus Rectal Nonsteroidal Anti-inflammatory Drugs: A Randomized Controlled Trial.
Koshitani T; Konaka Y; Ohishi T; Yasuda T; Morinushi T; Mita M; Masuda M; Nakano K; Fuki S; Nakagawa S
Pancreas; 2022 Jul; 51(6):663-670. PubMed ID: 36099496
[TBL] [Abstract][Full Text] [Related]
13. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis of pancreatitis with intravenous ketoprofen in a consecutive population of ERCP patients: a randomized double-blind placebo-controlled trial.
de Quadros Onófrio F; Lima JCP; Watte G; Lehmen RL; Oba D; Camargo G; Dos Santos CEO
Surg Endosc; 2017 May; 31(5):2317-2324. PubMed ID: 27651353
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis.
Elmunzer BJ; Scheiman JM; Lehman GA; Chak A; Mosler P; Higgins PD; Hayward RA; Romagnuolo J; Elta GH; Sherman S; Waljee AK; Repaka A; Atkinson MR; Cote GA; Kwon RS; McHenry L; Piraka CR; Wamsteker EJ; Watkins JL; Korsnes SJ; Schmidt SE; Turner SM; Nicholson S; Fogel EL;
N Engl J Med; 2012 Apr; 366(15):1414-22. PubMed ID: 22494121
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A
Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176
[TBL] [Abstract][Full Text] [Related]
17. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
[TBL] [Abstract][Full Text] [Related]
18. Can postendoscopic retrograde cholangiopancreatography pancreatitis be prevented by a pharmacological approach?
Cheon YK
Korean J Intern Med; 2013 Mar; 28(2):141-8. PubMed ID: 23525264
[TBL] [Abstract][Full Text] [Related]
19. Does melatonin addition to indomethacin decrease post endoscopic retrograde cholangiopancreatography pancreatitis? A randomized double-blind controlled trial.
Sadeghi A; Abbasinazari M; Asadzadeh Aghdaei H; Abdi S; Hatami B; Rasoolinezhad M; Jamshidzadeh S; Saadati S
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1350-1355. PubMed ID: 31524774
[TBL] [Abstract][Full Text] [Related]
20. Does rectal ketoprofen prevent post ERCP pancreatitis?
Makhoul E; El Mir J; Harb M
Arab J Gastroenterol; 2019 Sep; 20(3):141-144. PubMed ID: 31582291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]